SCHEMBL6438693

SCHEMBL6438693

Cn1ncc(/C=C/C(=O)Nc2ccc(CO[PH](=O)O)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.43
HTR2C P28335 2/20 0.43
CHRM1 P11229 1/20 0.42
MCHR1 Q99705 1/20 0.42
HDAC1 Q13547 3/20 0.41
HDAC2 Q92769 3/20 0.41
CCNC P24863 4/20 0.41
CDK8 P49336 4/20 0.41
CDK19 Q9BWU1 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
MMP1 P03956 2/20 0.39
MMP2 P08253 2/20 0.39
MMP9 P14780 2/20 0.39
MEN1 O00255 4/20 0.39
MAPT P10636 4/20 0.39
KMT2A Q03164 4/20 0.39
LMNA P02545 4/20 0.39
MAPK1 P28482 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6438698 1.00 HTR2A (0.43) HTR2AHTR2CCHRM1MCHR1HDAC1
SCHEMBL6438696 0.94 HTR2A (0.44) HTR2AHTR2CCHRM1MCHR1HDAC1
SCHEMBL6434499 0.91 CCNC (0.42) HTR2AHTR2CCCNCCDK8CDK19
SCHEMBL29208306 0.91 CCNC (0.42) HTR2AHTR2CCCNCCDK8CDK19
SCHEMBL6434504 0.91 CCNC (0.42) HTR2AHTR2CCCNCCDK8CDK19
SCHEMBL6431330 0.91 HDAC1 (0.41) HTR2AHTR2CHDAC1HDAC2CCNC
SCHEMBL6431320 0.91 HDAC1 (0.41) HTR2AHTR2CHDAC1HDAC2CCNC
SCHEMBL6429439 0.91 CCNC (0.45) HDAC1HDAC2CCNCCDK8CDK19
SCHEMBL6429433 0.91 CCNC (0.45) HDAC1HDAC2CCNCCDK8CDK19
SCHEMBL6429582 0.90 HDAC1 (0.45) HDAC1HDAC2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556032-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY Takeda Pharmaceutical Company Limited (JP) 2005-07-27 EP disclosed
WO-2004039365-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-13 WO disclosed